Charmacy Pharmaceutical Co., Ltd. (2289.HK)
HKD 9.0
(0.0%)
HKD 9.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 30.39 Million CNY | 92.89% |
| 2022 | 15.75 Million CNY | -81.86% |
| 2021 | 86.86 Million CNY | -26.67% |
| 2020 | 118.45 Million CNY | -6.25% |
| 2019 | 126.35 Million CNY | 40.39% |
| 2018 | 90 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2023 Q4 | 30.39 Million CNY | 120.26% |
| 2023 Q2 | 13.79 Million CNY | -12.42% |
| 2023 FY | 30.39 Million CNY | 92.89% |
| 2022 FY | 15.75 Million CNY | -81.86% |
| 2022 Q4 | 15.75 Million CNY | -77.83% |
| 2022 Q2 | 71.07 Million CNY | -18.18% |
| 2021 FY | 86.86 Million CNY | -26.67% |
| 2021 Q4 | 86.86 Million CNY | -15.38% |
| 2021 Q2 | 102.66 Million CNY | -13.33% |
| 2020 Q2 | 134.24 Million CNY | 6.25% |
| 2020 FY | 118.45 Million CNY | -6.25% |
| 2020 Q4 | 118.45 Million CNY | -11.76% |
| 2019 FY | 126.35 Million CNY | 40.39% |
| 2019 Q4 | 126.35 Million CNY | 40.39% |
| 2019 Q2 | 90 Million CNY | 0.0% |
| 2018 FY | 90 Million CNY | 0.0% |
| 2018 Q4 | 90 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Wanjia Group Holdings Limited | 11.54 Million HKD | -163.232% |
| China Health Group Limited | - HKD | -Infinity% |
| Tai United Holdings Limited | 299 Thousand HKD | -10063.919% |